Streetbeat News

Analyst Ratings

DGX

JP Morgan analyst John Stansel has maintained a Neutral rating on Quest Diagnostics (NYSE:DGX) and increased the price target from $148 to $149.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:34 pm

MOH

JP Morgan analyst Calvin Sternick has maintained an Overweight rating on Molina Healthcare (NYSE:MOH) and increased the price target from $367 to $392.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:33 pm

MCK

JP Morgan analyst Lisa Gill has maintained an Overweight rating on McKesson (NYSE:MCK) and increased the price target from $495 to $514.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:30 pm

M

JP Morgan analyst Matthew Boss has maintained an Overweight rating on Macy's (NYSE:M) and increased the price target from $16 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:28 pm

NAPA

BMO Capital analyst Andrew Strelzik has maintained a Market Perform rating on Duckhorn Portfolio (NYSE:NAPA) but lowered the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:27 pm

SQM

BMO Capital analyst Joel Jackson has maintained an Outperform rating on Sociedad Quimica Y Minera (NYSE:SQM) but has reduced the price target from $80 to $75.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:25 pm

LH

JP Morgan analyst John Stansel has maintained an Overweight rating on Laboratory Corp (NYSE:LH) and increased the price target from $259 to $261.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:24 pm

CAH

JP Morgan analyst Lisa Gill has maintained a Neutral rating on Cardinal Health (NYSE:CAH) and increased the price target from $101 to $112.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:21 pm

WMT

BMO Capital analyst Kelly Bania has maintained an Outperform rating on Walmart (NYSE:WMT) but has reduced the price target from $180 to $175.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:21 pm